NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

If they know the number alive as of ASCO (unless the CRO doesn't even inform them on that), then I agree, they may be telegraphing a 32% improvement from November 2018, as you suggest, in the KM life expectancy at 5 years.

From today's share holder note...

For those of you who didn’t get a chance to view the webcast, we would encourage you to look at the replay on our website and follow along using the PowerPoint presentation. Following it this way should better provide more perspective on the progress we have been making.

From Lykiri...

My conclusion: the survival data appear consistent with the blinded interim data of the trial. All the numbers they gave us in the past were based on the ITT group = 331 patients.
So,

data NOV 2018::
50 patients are expected to live for 58.4 months or more.

data JUNE 2019
66 patients (20% of the blinded ITT group= 331 patients) are expected to live for 60 months or more!

That is a 32% improvement!